Abstract
Apatinib, an anti-tumor drug selectively targeting VEGFR2 (Vascular Endothelia Growth Factor Recpetor-2), has been proven effective in Chinese patient......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
